Report Detail
Global Novel Coronavirus (COVID-19) Drugs Market Size, Status and Forecast 2020-2026
- RnM3944737 |
- 08 April, 2020 |
- Global |
- 97 Pages |
- QYResearch |
- Medical Industry
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Novel Coronavirus (COVID-19) Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Novel Coronavirus (COVID-19) Drugs industry.
Based on our recent survey, we have several different scenarios about the Novel Coronavirus (COVID-19) Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Novel Coronavirus (COVID-19) Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Novel Coronavirus (COVID-19) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Novel Coronavirus (COVID-19) Drugs market in terms of revenue.
Players, stakeholders, and other participants in the global Novel Coronavirus (COVID-19) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Novel Coronavirus (COVID-19) Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Novel Coronavirus (COVID-19) Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Novel Coronavirus (COVID-19) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Novel Coronavirus (COVID-19) Drugs market.
The following players are covered in this report:
National Institute of Allergy and Infectious Diseases
King Abdullah International Medical Research Center
CanSino Biologics
Philipps University Marburg Medical Center
Naval Medical Research Center
SAB Biotherapeutics
Novavax
Gilead
Inovio
Entos Pharmaceuticals
Novel Coronavirus (COVID-19) Drugs Breakdown Data by Type
Vaccine
Tablet
Novel Coronavirus (COVID-19) Drugs Breakdown Data by Application
Adults (Non-pregnant)
Pregnant Women
Children
Olders
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Novel Coronavirus (COVID-19) Drugs Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Vaccine
- 1.4.3 Tablet
- 1.5 Market by Application
- 1.5.1 Global Novel Coronavirus (COVID-19) Drugs Market Share by Application: 2020 VS 2026
- 1.5.2 Adults (Non-pregnant)
- 1.5.3 Pregnant Women
- 1.5.4 Children
- 1.5.5 Olders
- 1.6 Coronavirus Disease 2019 (Covid-19): Novel Coronavirus (COVID-19) Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Novel Coronavirus (COVID-19) Drugs Industry
- 1.6.1.1 Novel Coronavirus (COVID-19) Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Novel Coronavirus (COVID-19) Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Novel Coronavirus (COVID-19) Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Novel Coronavirus (COVID-19) Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Novel Coronavirus (COVID-19) Drugs Market Perspective (2015-2026)
- 2.2 Novel Coronavirus (COVID-19) Drugs Growth Trends by Regions
- 2.2.1 Novel Coronavirus (COVID-19) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Novel Coronavirus (COVID-19) Drugs Historic Market Share by Regions (2015-2020)
- 2.2.3 Novel Coronavirus (COVID-19) Drugs Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Novel Coronavirus (COVID-19) Drugs Market Growth Strategy
- 2.3.6 Primary Interviews with Key Novel Coronavirus (COVID-19) Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Novel Coronavirus (COVID-19) Drugs Players by Market Size
- 3.1.1 Global Top Novel Coronavirus (COVID-19) Drugs Players by Revenue (2015-2020)
- 3.1.2 Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Novel Coronavirus (COVID-19) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Novel Coronavirus (COVID-19) Drugs Market Concentration Ratio
- 3.2.1 Global Novel Coronavirus (COVID-19) Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Novel Coronavirus (COVID-19) Drugs Revenue in 2019
- 3.3 Novel Coronavirus (COVID-19) Drugs Key Players Head office and Area Served
- 3.4 Key Players Novel Coronavirus (COVID-19) Drugs Product Solution and Service
- 3.5 Date of Enter into Novel Coronavirus (COVID-19) Drugs Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Novel Coronavirus (COVID-19) Drugs Historic Market Size by Type (2015-2020)
- 4.2 Global Novel Coronavirus (COVID-19) Drugs Forecasted Market Size by Type (2021-2026)
5 Novel Coronavirus (COVID-19) Drugs Breakdown Data by Application (2015-2026)
- 5.1 Global Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020)
- 5.2 Global Novel Coronavirus (COVID-19) Drugs Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Novel Coronavirus (COVID-19) Drugs Market Size (2015-2020)
- 6.2 Novel Coronavirus (COVID-19) Drugs Key Players in North America (2019-2020)
- 6.3 North America Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020)
- 6.4 North America Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Novel Coronavirus (COVID-19) Drugs Market Size (2015-2020)
- 7.2 Novel Coronavirus (COVID-19) Drugs Key Players in Europe (2019-2020)
- 7.3 Europe Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020)
- 7.4 Europe Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020)
8 China
- 8.1 China Novel Coronavirus (COVID-19) Drugs Market Size (2015-2020)
- 8.2 Novel Coronavirus (COVID-19) Drugs Key Players in China (2019-2020)
- 8.3 China Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020)
- 8.4 China Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Novel Coronavirus (COVID-19) Drugs Market Size (2015-2020)
- 9.2 Novel Coronavirus (COVID-19) Drugs Key Players in Japan (2019-2020)
- 9.3 Japan Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020)
- 9.4 Japan Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020)
10 Key Players Profiles
- 10.1 National Institute of Allergy and Infectious Diseases
- 10.1.1 National Institute of Allergy and Infectious Diseases Company Details
- 10.1.2 National Institute of Allergy and Infectious Diseases Business Overview and Its Total Revenue
- 10.1.3 National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Introduction
- 10.1.4 National Institute of Allergy and Infectious Diseases Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020))
- 10.1.5 National Institute of Allergy and Infectious Diseases Recent Development
- 10.2 King Abdullah International Medical Research Center
- 10.2.1 King Abdullah International Medical Research Center Company Details
- 10.2.2 King Abdullah International Medical Research Center Business Overview and Its Total Revenue
- 10.2.3 King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Introduction
- 10.2.4 King Abdullah International Medical Research Center Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.2.5 King Abdullah International Medical Research Center Recent Development
- 10.3 CanSino Biologics
- 10.3.1 CanSino Biologics Company Details
- 10.3.2 CanSino Biologics Business Overview and Its Total Revenue
- 10.3.3 CanSino Biologics Novel Coronavirus (COVID-19) Drugs Introduction
- 10.3.4 CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.3.5 CanSino Biologics Recent Development
- 10.4 Philipps University Marburg Medical Center
- 10.4.1 Philipps University Marburg Medical Center Company Details
- 10.4.2 Philipps University Marburg Medical Center Business Overview and Its Total Revenue
- 10.4.3 Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Introduction
- 10.4.4 Philipps University Marburg Medical Center Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.4.5 Philipps University Marburg Medical Center Recent Development
- 10.5 Naval Medical Research Center
- 10.5.1 Naval Medical Research Center Company Details
- 10.5.2 Naval Medical Research Center Business Overview and Its Total Revenue
- 10.5.3 Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Introduction
- 10.5.4 Naval Medical Research Center Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.5.5 Naval Medical Research Center Recent Development
- 10.6 SAB Biotherapeutics
- 10.6.1 SAB Biotherapeutics Company Details
- 10.6.2 SAB Biotherapeutics Business Overview and Its Total Revenue
- 10.6.3 SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Introduction
- 10.6.4 SAB Biotherapeutics Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.6.5 SAB Biotherapeutics Recent Development
- 10.7 Novavax
- 10.7.1 Novavax Company Details
- 10.7.2 Novavax Business Overview and Its Total Revenue
- 10.7.3 Novavax Novel Coronavirus (COVID-19) Drugs Introduction
- 10.7.4 Novavax Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.7.5 Novavax Recent Development
- 10.8 Gilead
- 10.8.1 Gilead Company Details
- 10.8.2 Gilead Business Overview and Its Total Revenue
- 10.8.3 Gilead Novel Coronavirus (COVID-19) Drugs Introduction
- 10.8.4 Gilead Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.8.5 Gilead Recent Development
- 10.9 Inovio
- 10.9.1 Inovio Company Details
- 10.9.2 Inovio Business Overview and Its Total Revenue
- 10.9.3 Inovio Novel Coronavirus (COVID-19) Drugs Introduction
- 10.9.4 Inovio Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.9.5 Inovio Recent Development
- 10.10 Entos Pharmaceuticals
- 10.10.1 Entos Pharmaceuticals Company Details
- 10.10.2 Entos Pharmaceuticals Business Overview and Its Total Revenue
- 10.10.3 Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Introduction
- 10.10.4 Entos Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Drugs Business (2015-2020)
- 10.10.5 Entos Pharmaceuticals Recent Development
11 Analyst's Viewpoints/Conclusions
12 Appendix
- 12.1 Research Methodology
- 12.1.1 Methodology/Research Approach
- 12.1.2 Data Source
- 12.2 Disclaimer
Summary:
Get latest Market Research Reports on Novel Coronavirus (COVID-19) Drugs. Industry analysis & Market Report on Novel Coronavirus (COVID-19) Drugs is a syndicated market report, published as Global Novel Coronavirus (COVID-19) Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Novel Coronavirus (COVID-19) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
